Potential Benefit of r-hLH Addition in Patients Aged 35 to 40 Under Ovarian Stimulation Treatment

NCT06571214 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Infertility

Interventions

DRUG: Recombinant Human Follitropin Alfa Solution for Injection (Gonal-f®)
DRUG: Recombinant Human Lutropin alfa for Injection (r-hLH, Luveris®)

Sponsor

Nanjing University